Adrian Kurz1, Nathan Evaniew1, Marco Yeung1, Kristian Samuelsson2,3, Devin Peterson4, Olufemi R Ayeni5. 1. Division of Orthopaedics, Department of Surgery, McMaster University, 293 Wellington St. N, Hamilton, ON, L8L 8E7, Canada. 2. Department of Orthopaedics, Sahlgrenska University Hospital, Mölndal, Sweden. 3. Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. 4. Division of Orthopaedics, Department of Surgery, McMaster University, 1200 Main St West, 4E15, Hamilton, ON, L8N 3Z5, Canada. 5. Division of Orthopaedics, Department of Surgery, McMaster University, 1200 Main St West, 4E15, Hamilton, ON, L8N 3Z5, Canada. ayenif@mcmaster.ca.
Abstract
PURPOSE: This systematic review examined the methodological credibility and quality of reporting of all meta-analyses which have compared bone-patellar tendon-bone (BPTB) versus hamstring tendon (HT) for anterior cruciate ligament (ACL) reconstruction (ACLR). METHODS: EMBASE, MEDLINE, and The Cochrane Library were systematically searched, and two reviewers independently assessed eligibility, credibility according to the Users' Guide to medical literature, and completeness of reporting according to the preferred reporting items for systematic review and meta-analyses (PRISMA) checklist. Inter-rater agreement was quantified using Kappa, and we used Pearson's correlation coefficient to evaluate potential associations. RESULTS: Seventeen meta-analyses were identified comparing BPTB versus HT for ACLR. The majority of meta-analyses were published in 2011 (5; 29 %), and North America was the most common continent of publication (6; 35 %). The three most commonly reported outcomes were stability (82 %), complications (76 %), and function (return to sport, IKDC score) (71 %). The median number of satisfactorily reported items in the Users' Guide was three out of seven (IQR 2-4). The median number of satisfactorily reported items in PRISMA for the meta-analyses was 20 out of 27 (IQR 19-22). CONCLUSION: The credibility of the meta-analyses comparing BPTB versus HT autograft for ACLR although limited is improving with time. Earlier studies had limited methodological rigour; however, the more recent studies have shown promise in improved methodology. The study findings suggest that decisions should be made on a case-to-case basis with coordination of patient factors and preferences as well as surgeon experience on the background of the best available evidence. LEVEL OF EVIDENCE: IV.
PURPOSE: This systematic review examined the methodological credibility and quality of reporting of all meta-analyses which have compared bone-patellar tendon-bone (BPTB) versus hamstring tendon (HT) for anterior cruciate ligament (ACL) reconstruction (ACLR). METHODS: EMBASE, MEDLINE, and The Cochrane Library were systematically searched, and two reviewers independently assessed eligibility, credibility according to the Users' Guide to medical literature, and completeness of reporting according to the preferred reporting items for systematic review and meta-analyses (PRISMA) checklist. Inter-rater agreement was quantified using Kappa, and we used Pearson's correlation coefficient to evaluate potential associations. RESULTS: Seventeen meta-analyses were identified comparing BPTB versus HT for ACLR. The majority of meta-analyses were published in 2011 (5; 29 %), and North America was the most common continent of publication (6; 35 %). The three most commonly reported outcomes were stability (82 %), complications (76 %), and function (return to sport, IKDC score) (71 %). The median number of satisfactorily reported items in the Users' Guide was three out of seven (IQR 2-4). The median number of satisfactorily reported items in PRISMA for the meta-analyses was 20 out of 27 (IQR 19-22). CONCLUSION: The credibility of the meta-analyses comparing BPTB versus HT autograft for ACLR although limited is improving with time. Earlier studies had limited methodological rigour; however, the more recent studies have shown promise in improved methodology. The study findings suggest that decisions should be made on a case-to-case basis with coordination of patient factors and preferences as well as surgeon experience on the background of the best available evidence. LEVEL OF EVIDENCE: IV.
Authors: P J Devereaux; Peter T-L Choi; Samer El-Dika; Mohit Bhandari; Victor M Montori; Holger J Schünemann; Amit X Garg; Jason W Busse; Diane Heels-Ansdell; William A Ghali; Braden J Manns; Gordon H Guyatt Journal: J Clin Epidemiol Date: 2004-12 Impact factor: 6.437
Authors: Bruce D Beynnon; Robert J Johnson; Braden C Fleming; Pekka Kannus; Michael Kaplan; John Samani; Per Renström Journal: J Bone Joint Surg Am Date: 2002-09 Impact factor: 5.284
Authors: Fahed Herbawi; Mario Lozano-Lozano; Maria Lopez-Garzon; Paula Postigo-Martin; Lucia Ortiz-Comino; Jose Luis Martin-Alguacil; Manuel Arroyo-Morales; Carolina Fernandez-Lao Journal: Int J Environ Res Public Health Date: 2022-06-01 Impact factor: 4.614
Authors: Luiz Gabriel Betoni Guglielmetti; Victor Eduardo Roman Salas; Pedro Baches Jorge; Fabrício Roberto Severino; Aires Duarte; Victor Marques de Oliveira; Ricardo de Paula Leite Cury Journal: Orthop J Sports Med Date: 2021-09-24